High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

International Journal of Cancer

Volumn 84, Issue 1, 1999, Pages 44-48

  McCarthy, Kevin ^a   Maguire, Teresa ^a   McGreal, Gerald ^a   McDermott, Enda ^a   O'Higgins, Niall ^a   Duffy, Michael J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER SIZE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0032963210     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990219)84:1<44::AID-IJC9>3.0.CO;2-P     Document Type: Article

References (24)

1. ANDREASEN, P., KJOLLER, L., CHRISTENSEN, L. and DUFFY, M.J., The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer, 72, 1-22 (1997).
2. BIGG, H.F., SHI, Y.E., LIU, Y.E., STEFFENSON, B. and OVERALL, C.M., Specific, high affinity binding of tissue inhibitor of metalloproteinase-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 hinds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J. biol. Chem., 272, 15496-15500 (1997).
3. CHAMBERS, A.F. and MATRISIAN, L.M., Changing views of the role of matrix metalloproteinases in metastasis. J. nat. Cancer Inst., 89, 1260-1270 (1997).
4. CLAFFEY, K.P. and ROBINSON, G.S., Regulation of VEGF/VPF expression in tumor cells: consequence for tumor growth and metastasis. Cancer Metastasis Rev., 15, 165-176 (1996).
5. DUFFY, M.J., Do proteases play a role in cancer invasion and metastasis? Europ. J. Cancer clin. Oncol., 23, 583-589 (1987).
6. DUFFY, M.J., Proteases as prognostic markers in cancer. Clin. Cancer Res., 2, 613-618 (1996a).
7. DUFFY, M.J., The biochemistry of metastasis. Adv. clin. Chem., 32, 135-166 (1996b).
8. DUFFY, M.J., BLASER, J., DUGGAN, C., MCDERMOTT, E., O'HIGGINS, N., FENNELLY, J.J. and TSCHESCHE, H., Assay of matrix metal loprotease types 8 and 9 by ELISA in human breast cancer. Brit. J. Cancer, 71, 1025-1028 (1995).
9. DUFFY, M.J., O'SIORAIN, L., WALDRON, B. and SMITH, C., Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies. Clin. Chem., 32, 1972-1974 (1986).
10. FABUNMI, R.P., BAKER, A.H., MURRAY, E.J., BOOTH, R.F.G. and NEWBY, A.C., Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem. J., 315, 335-342 (1996).
11. FONG, K.M., KIDA, Y., ZIMMERMAN, P.V. and SMITH, P.J., TIMP-1 and adverse prognosis in non-small cell lung cancer. Clin. Cancer Res., 2, 1369-1372 (1996).
12. GASSON, J.C., GOLDE, D.W., KAUFMAN, S.E., WESTBROOK, C.A., HEWICK, R.J., WONG, G.G., TEMPLE, P.A., LEARY, A.C., BROWN, E.L., ORR, E.C. and CLARK, S.C., Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature (Lond.), 315, 768-771 (1985).
13. GOLDBERG, G.I., MARMER, B.L., GRANT, G.G., EISEN, A.Z., WILHELM, S. and HE, C.S., Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc. nat. Acad. Sci. (Wash.) 86, 8207-8211 (1989).
14. GOMEZ, D.E., ALONSO, D.F. YOSHIJI, H. and THORGEIRSSON, U.P., Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eump. J. Cell Biol., 74, 111-122 (1997).
15. GRIGNON, D.J., SAKR, W., TOTH, M., RAVERY, V., ANGULO, J., SHAMSA, F., PONTES, J.E., CRISSMAN, J.C. and FRIDMAN, R., High levels of tissue inhibitor of metalloproteinases-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res., 56, 1654-1659 (1996).
16. KOSSAKOWSKA, A.E., URBANSKI, S.J. and EDWARDS, D.R., Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood, 77, 2475-2481 (1991).
17. LINDSAY, C.K., THORGEIRSSON, U.P., TSUDA, H. and HIROHASHI, S., Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/ gelatinase messenger RNAs in human breast cancer. Hum. Pathol., 28, 359-366 (1997).
18. REE, A.H., FLØRENES, V.A., BERG, J.P., MAELANDSMO, G.M., NESLAND, J.M. and FORSTAD, Ø., High levels of mRNA for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of metastases. Clin. Cancer Res., 3, 1623-1628 (1997).
19. REILLY, D., CHRISTENSEN, L., DUCH, M., NOLAN, N., DUFFY, M.J. and ANDREASEN, P.A., Type-1 plasminogen activator inhibitor in human breast carcinomas. Int. J. Cancer, 50, 208-214 (1992).
20. VISSCHER, D.W., HÖYHTYÄ M., OTTOSEM, S.K., LIANG, C.M., SARKAR, F.H., CRISSMAN, J.D. and FRIDMAN, R., Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer, 59, 339-344 (1994).
21. WILHELM, S.M., COLLIER, I.E., MARMER, B.L., EISEN, A.Z., GRANT, G.A. and GOLDBERG, G.I., SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. biol. Chem., 264, 17213-17221 (1989).
22. YOSHIJI, H., GOMEZ, D.E. and THORGEIRSSON, U.P., Enhanced RNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human breast cancer. Int. J. Cancer, 69, 131-134 (1996).
23. YOSHIJI, H., HARRIS, S.R., RASO, E., GOMEZ, D.E., LINDSAY, C.K., SHIBUYA, M., SINHA, C.C. and THORGEIRSSON, U.P., Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. Int. J. Cancer. 75, 81-87 (1998).
24. ZENG, Z.S., COHEN, A.M., ZHANG, Z.F., STETLER-STEVENSON, W. and GUILLEM, J.G., Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin. Cancer Res., 1, 899-906 (1995).